<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01469728</url>
  </required_header>
  <id_info>
    <org_study_id>107/07</org_study_id>
    <secondary_id>#20112</secondary_id>
    <nct_id>NCT01469728</nct_id>
  </id_info>
  <brief_title>Comparison of Thoracoscopic Talc Pleurodesis by Thoracic Epidural or General Anesthesia</brief_title>
  <official_title>Randomized Study of Thoracoscopic Talc Pleurodesis Performed by Thoracic Epidural or General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rome Tor Vergata</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Video-assisted thoracoscopic surgery (VATS) talc pleurodesis is often carried out in patients
      with malignant recurrent pleural effusion to relieve symptoms and prevent recurrence.

      General anesthesia and one lung ventilation is the standard type of anesthesia employed for
      VATS although recently, thoracic epidural anesthesia (TEA) in awake spontaneously ventilating
      patients is being increasingly employed to perform several cardio-thoracic surgery procedures
      in an attempt of minimize operative risks and facilitate resumption of daily-life activity.

      The investigators have reasoned that for a simple and palliative procedure such as talc
      pleurodesis in cancer patients is, use of general anesthesia and one-lung ventilation might
      be considered a potential cause of morbidity and delayed recovery. The investigators have
      also hypothesized TEA could be considered an optimal type of anesthesia in this setting
      leading to a fast recovery a reduced overall workload in medical care.

      In this single-center randomized study, the investigators have comparatively assessed the
      impact of awake TEA versus general anesthesia and one-lung ventilation on comprehensive
      results of VATS talc pleurodesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grade of perioperative medical care (PMC).</measure>
    <time_frame>participants are followed for the duration of hospital stay; average of 5 days</time_frame>
    <description>PMC is aimed at evaluating the overall workload in medical care throughout the the entire perioperative period and until discharge. PMC was computed as a comprehensive multidimensional variable including hospitalization time and extra-routine nursing/clinical/pharmacological requirements and costs(grades 1-3).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Postoperatively at 3h,12h and 24h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative changes in blood gases</measure>
    <time_frame>Imediately before operation, at end-procedure, postoperatively at 1h and 24h</time_frame>
    <description>Ratio of arterial oxygen tension to fraction of inspired oxygen (PaO2/FiO2), arterial carbon dioxide tension (PaCO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative changes in cardiocirculatory variables including heart rate (HR) and mean arteial pressure (MAP)</measure>
    <time_frame>Immediately before the operation, at end-procedure, postoperatively at 1h and 24h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative changes in spirometric variables</measure>
    <time_frame>Postoperatively at 3h,12h and 24h</time_frame>
    <description>Forced expiratory volume in one second(FEV1), forced vital capacity (FVC), peak expiratory flow (PEF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>from day of operation to discharge; average, 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>from day of operation to discharge; average, 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Redo pleurodesis</measure>
    <time_frame>From date of operation until the date of redo pleurodesis or assessed every 6 months or until date of death from any cause</time_frame>
    <description>Need of reoperation because of recurrence of the pleural effusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative mortality</measure>
    <time_frame>from day of operation for up to 30 days postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pleural Effusion</condition>
  <arm_group>
    <arm_group_label>Awake VATS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thoracoscopic talc pleurodesis performed in awake patients through sole thoracic epidural anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-awake VATS talc pleurodesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracoscopic talc pleurodesis performed through sole general anesthesia and one-lung ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-awake VATS talc pleurodesis</intervention_name>
    <description>Thoracoscopic talc pleurodesis performed through sole general anesthesia and one-lung ventilation</description>
    <arm_group_label>Non-awake VATS talc pleurodesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Awake VATS talc pleurodesis</intervention_name>
    <description>Thoracoscopic talc pleurodesis performed in awake patients through sole thoracic epidural anesthesia.</description>
    <arm_group_label>Awake VATS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recurrent pleural effusion at the computed tomography occupying at least 1/3 of the
             hemithorax in patients with recent history of malignancy.

          -  Karnofsky performance status â‰¥ 50

          -  ASA score II-III

          -  Acceptance of the randomly assigned anesthesia protocol

          -  Radiologic evidence of lung re-expansion after previous drainage/thoracentesis

          -  Absence of blood clotting disorders (INR &lt; 1.5)

          -  No contraindications to TEA

          -  No neurological or psychiatric disturbance contraindicating awake surgery

        Exclusion Criteria:

          -  Patients refusal of random assignment to treatment arm

          -  Patients refusal or noncompliance to TEA

          -  Patients refusal or noncompliance to general anesthesia and one-lung ventilation

          -  Unfavourable anatomy for TEA

          -  Previous surgery of the thoracic spine

          -  Coagulation disorders (thromboplastin time &lt; 80%, prothrombin time &gt; 40 sec, platelet
             count &lt; 200/nL or bleeding disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Policlinico Tor Vergata University</name>
      <address>
        <city>Rome</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Pompeo E, Tacconi F, Mineo TC. Comparative results of non-resectional lung volume reduction performed by awake or non-awake anesthesia. Eur J Cardiothorac Surg. 2011 Apr;39(4):e51-8. doi: 10.1016/j.ejcts.2010.11.071.</citation>
    <PMID>21397783</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, Tacconi F, Frasca L, Mineo TC. Awake thoracoscopic bullaplasty. Eur J Cardiothorac Surg. 2011 Jun;39(6):1012-7. doi: 10.1016/j.ejcts.2010.09.029. Epub 2010 Oct 25.</citation>
    <PMID>20980159</PMID>
  </reference>
  <reference>
    <citation>Vanni G, Tacconi F, Sellitri F, Ambrogi V, Mineo TC, Pompeo E. Impact of awake videothoracoscopic surgery on postoperative lymphocyte responses. Ann Thorac Surg. 2010 Sep;90(3):973-8. doi: 10.1016/j.athoracsur.2010.04.070.</citation>
    <PMID>20732526</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, Tacconi F, Mineo TC. Awake video-assisted thoracoscopic biopsy in complex anterior mediastinal masses. Thorac Surg Clin. 2010 May;20(2):225-33. doi: 10.1016/j.thorsurg.2010.01.003. Review.</citation>
    <PMID>20451133</PMID>
  </reference>
  <reference>
    <citation>Tacconi F, Pompeo E, Sellitri F, Mineo TC. Surgical stress hormones response is reduced after awake videothoracoscopy. Interact Cardiovasc Thorac Surg. 2010 May;10(5):666-71. doi: 10.1510/icvts.2009.224139. Epub 2010 Feb 23.</citation>
    <PMID>20179134</PMID>
  </reference>
  <reference>
    <citation>Tacconi F, Pompeo E, Fabbi E, Mineo TC. Awake video-assisted pleural decortication for empyema thoracis. Eur J Cardiothorac Surg. 2010 Mar;37(3):594-601. doi: 10.1016/j.ejcts.2009.08.003. Epub 2009 Sep 16.</citation>
    <PMID>19762250</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, Mineo TC. Awake operative videothoracoscopic pulmonary resections. Thorac Surg Clin. 2008 Aug;18(3):311-20. doi: 10.1016/j.thorsurg.2008.04.006. Review.</citation>
    <PMID>18831509</PMID>
  </reference>
  <reference>
    <citation>Pompeo E, Mineo TC. Two-year improvement in multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity index after nonresectional lung volume reduction surgery in awake patients. Ann Thorac Surg. 2007 Dec;84(6):1862-9; discussion 1862-9.</citation>
    <PMID>18036900</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2011</study_first_submitted>
  <study_first_submitted_qc>November 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2011</study_first_posted>
  <last_update_submitted>November 8, 2011</last_update_submitted>
  <last_update_submitted_qc>November 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rome Tor Vergata</investigator_affiliation>
    <investigator_full_name>Eugenio Pompeo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>VATS</keyword>
  <keyword>awake thoracic surgery</keyword>
  <keyword>pleurodesis</keyword>
  <keyword>talc</keyword>
  <keyword>TEA</keyword>
  <keyword>epidural anesthesia</keyword>
  <keyword>Video-Assisted</keyword>
  <keyword>Anesthesia Epidural</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

